Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
From core to coating, there is a lot to consider when it comes to developing and optimizing a solid dosage formulation.
Sitting Down With... David Schoneker, Global Regulatory Director, Strategic Relationships at Colorcon.
With David Schoneker
High quality excipients make all the difference to the drug development process. And yet, for years, excipients were often overlooked by the industry.
The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.
The Medicine Maker speaks with Christophe Le Ret, Global Marketing Director of Umicore
The Medicine Maker speaks with Angela Strzelecki, Global Business Director of Dupont
A good CDMO is a true partner with advice on getting the most from your molecule.
CPhI Worldwide will return on October 9-11, 2018, at the IFEMA, Feria de Madrid, Spain.
Interest in cannabinoid drug development is growing. The potential market – and the opportunity to treat unmet patient needs – is enormous.
Beatriz Domínguez and Ahir Pushpanath
Enzyme engineering has opened up new possibilities in biocatalysis, but computational techniques and smart libraries also make wildtypes feasible. The choice is yours.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.